%0 Journal Article
%A Zhao, Binghao
%A Qi, Hao
%A Wu, Jiaming
%A Ma, Wenbin
%T Cemiplimab Plus Chemotherapy Could Be a First-Line Option for Advanced and Metastatic NSCLC: Results From the Phase 3 EMPOWER-Lung 3 Part 2 Trial.
%J Journal of thoracic oncology
%V 18
%N 7
%@ 1556-0864
%C Amsterdam
%I Elsevier
%M DKFZ-2023-01257
%P e72 - e73
%D 2023
%Z #EA:D170#
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:37348996
%R 10.1016/j.jtho.2023.04.001
%U https://inrepo02.dkfz.de/record/277073